QTSI is designed to measure heterogeneity and changes in bone. It does this by comparing skeletal scans (CT, PET/CT) with statistical appearance models of normal bone, providing quantitation of disease. AIQ’s patented technology allows precise measurement of physiological changes in the skeleton over time, allowing physicians to track the response or progression of bone disease.
QTSI targets osteoporosis and degenerative joint disease (osteoarthritis).
Currently in late stage development.
NOT CLEARED FOR USE IN THE UNITED STATES.